Cisplatin Resistance and Redox-Metabolic Vulnerability: A Second Alteration

The development of drug resistance in tumors is a major obstacle to effective cancer chemotherapy and represents one of the most significant complications to improving long-term patient outcomes. Despite early positive responsiveness to platinum-based chemotherapy, the majority of lung cancer patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Wangpaichitr, Medhi, Theodoropoulos, George, Nguyen, Dan J. M., Wu, Chunjing, Spector, Sydney A., Feun, Lynn G., Savaraj, Niramol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304747/
https://www.ncbi.nlm.nih.gov/pubmed/34298999
http://dx.doi.org/10.3390/ijms22147379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304747/
https://www.ncbi.nlm.nih.gov/pubmed/34298999
http://dx.doi.org/10.3390/ijms22147379

Ejemplares similares